V. Hofmeister

发表

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

G. Ahlenstiel, J. Nattermann, H. Nischalke, 2005, The American journal of pathology.

Tumor stroma-associated antigens for anti-cancer immunotherapy

J. Becker, E. Bröcker, D. Schrama, 2006, Cancer Immunology, Immunotherapy.

HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.

J. Ellwart, Gülnihål Yüksekdag, F. Momburg, 2003, Human immunology.

HLA-G modulates immune responses by diverse receptor interactions.

V. Hofmeister, E. Weiss, 2003, Seminars in cancer biology.

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.

J. Dichgans, M. Weller, R. Hohlfeld, 2003, Brain : a journal of neurology.

MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib

C. Noelke, D. Schrama, R. Houben, 2009, Molecular Cancer Therapeutics.

Immune Escape Human Gliomas: An Alternative Strategy of A Functional Role of HLA-G Expression in

H. Wiendl, A. Melms, R. Meyermann, 2013 .

A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape1

M. Weller, H. Wiendl, J. Wischhusen, 2002, The Journal of Immunology.

Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands.

S. Maier, A. Brooks, C. Falk, 2004, Human immunology.

Anti-cancer therapies targeting the tumor stroma

J. Becker, D. Schrama, V. Hofmeister, 2007, Cancer Immunology, Immunotherapy.